Cargando…
Case Report: Collapsing Focal Segmental Glomerulosclerosis After Initiation of Ado-Trastuzumab Emtansine Therapy
Ado-trastuzumab emtansine (T-DM1) is an antibody–drug conjugate consisting of the monoclonal antibody trastuzumab linked to the maytansinoid DM1 with potential antineoplastic activity and is approved for human epidermal growth factor receptor 2 (HER2)-positive breast cancer. An analysis of the US Fo...
Autores principales: | Hakroush, Samy, Wulf, Svenja, Gallwas, Julia, Tampe, Björn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8667226/ https://www.ncbi.nlm.nih.gov/pubmed/34912725 http://dx.doi.org/10.3389/fonc.2021.796223 |
Ejemplares similares
-
Excellent Response with Ado-Trastuzumab Emtansine in a Patient with Relapsed Metastatic Breast Cancer Presenting with Pulmonary Lymphangitic Carcinomatosis
por: Yu, Zhou, et al.
Publicado: (2017) -
Ado-Trastuzumab Emtansine in Metastatic HER2-Positive Breast Cancer
por: Callahan, Rena
Publicado: (2014) -
Cytomegalovirus-induced collapsing focal segmental glomerulosclerosis
por: Grover, Vanya, et al.
Publicado: (2013) -
Collapsing Focal Segmental Glomerulosclerosis in Viral Infections
por: Muehlig, Anne K., et al.
Publicado: (2022) -
In-depth structural characterization of Kadcyla® (ado-trastuzumab emtansine) and its biosimilar candidate
por: Chen, Liuxi, et al.
Publicado: (2016)